glp-1 receptor agonist bcbs Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Current Insights, Advantages and Challenges

Dan McKees proposed fiscal year 2027 budget would remove GLP-1 drugs from Rhode Islands Medicaid formulary for weight loss, saving $6.3 million in general revenue

Earlier this year, Blue Cross Blue Shield said five GLP-1 drugs now account for nearly 20% of its pharmacy spend.

Clinical features A 42-yr-old patient with Barretts esophagus underwent repeat upper gastrointestinal endoscopy and ablation of dysplastic mucosa

GLP-1 receptor agonist drugs like Ozempic slow emptying of the stomach and bowel, affecting colonoscopy and endoscopy prep.

In a recent study, researchers found that GLP-1RA medications such as Ozempic and Wegovy are associated with a higher risk of post-endoscopy aspiration pneumonia.